Welcome to the
Hepatitis B Foundation
Top Stories 
PEG-IFN May Improve Response to Entecavir for HBV
March 11 – Adding pegylated interferon alfa-2a to entecavir increases treatment response in patients with chronic hepatitis B virus infection who are HBeAg positive, according to preliminary results from an international clinical trial. Read more.
Pennsylvania Biotech Center, Created by Hepatitis B Foundation Has Huge Economic Impact
March 8, 2013 - The PA Biotechnology Center, created by the Hepatitis B Foundation, has generated $579 million for the region and state, and 573 jobs over the past 4 years, according to the Economic Impact Study 2013, released by Byler Associates. View Video.
Justice Department Settles with the University of Medicine and Dentistry of New Jersey Over Discrimination Against People with Hepatitis B
March 5 – The U.S. Justice Department has reached a settlement with the University of Medicine and Dentistry of New Jersey that resolves complaints that some applicants were unlawfully excluded because they have hepatitis B. Under the settlement, UMDNJ will adopt a disability rights policy and allow the applicants to enroll. The Hepatitis B Foundation is proud to have played a role in successfully advocating for these students. Read more.
HBF Happenings
Register for the New Liver Cancer Webinar Series
Learn more about primary liver cancer prevention, screening, diagnosis and treatment from renowned medical experts in the field. The Hepatitis B Foundation is presenting free webinars that will focus on the 3 major causes – hepatitis B, hepatitis C and fatty liver disease – of this deadly cancer that is the fastest growing cancer in the U.S. while all other cancer rates are declining. Read more.
April 3 – Hepatitis C and Liver Cancer presented by Dr. Doug LaBrecque Register now!
The American Journal of Medicine Publishes HBF's Consensus Recommendations and Algorithm
Page last modified March 11, 2013
www.apaslconference.org
